Devi Jyoti, Kumar Roushan, Singh Khem, Gehlot Ashok, Bhushan Shashi, Kumar Sanjay
Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology (IHBT), Palampur, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Crit Rev Biotechnol. 2021 Jun;41(4):564-579. doi: 10.1080/07388551.2020.1869690. Epub 2021 Feb 14.
The current trends of consumer-driven demands for natural therapeutics and the availability of evidence-based phytopharmaceuticals from traditional knowledge has once again brought the medicinal plants into forefront of health. In 2019, World Health Organization global report on traditional and complementary medicine has also substantiated the revival of herbal medicine including its convergence with conventional medicine for the management and prevention of diseases. It means these industries need plenty of plant materials to meet the unprecedented demands of herbal formulations. However, it is pertinent to mention here that around 70-80% medicinal plants are sourced from the wild and most of such highly acclaimed plants are listed under Rare, Endangered and Threatened species by IUCN. Additionally, over 30% traditional health formulations are based on underground plant parts, which lead to the uprooting of plants. Overharvesting from limited plant populations, meager conventional cultivation and a rising fondness for natural products exerting enormous pressure on natural habitats. Therefore, the nondestructive means of phytochemical production employing biotechnological tools could be used for sustainable production and consumption patterns. In recent years, a number of reports described the use of adventitious roots induced under conditions for the extraction of phytochemicals on a sustainable basis. In this article, efforts are made to review recent developments in this area as well as understand the induction mechanisms of adventitious roots, their cultivation, probable factors that affect the growth and metabolite production, and assess the possibility of industrial scale production to meet the rising demands of natural herbs.
消费者对天然疗法的需求趋势以及基于传统知识的循证植物药的可得性,再次将药用植物推到了健康领域的前沿。2019年,世界卫生组织关于传统和补充医学的全球报告也证实了草药的复兴,包括其与传统医学在疾病管理和预防方面的融合。这意味着这些行业需要大量的植物材料来满足对草药制剂前所未有的需求。然而,在此需要提及的是,大约70%-80%的药用植物来自野生,其中大多数备受赞誉的植物被世界自然保护联盟列为珍稀、濒危和受威胁物种。此外,超过30%的传统健康制剂基于植物地下部分,这导致了植物的连根拔起。从有限的植物种群中过度采收、传统种植稀少以及对天然产品的喜爱不断增加,给自然栖息地带来了巨大压力。因此,利用生物技术工具进行植物化学物质生产的无损方法可用于可持续的生产和消费模式。近年来,许多报告描述了在特定条件下诱导不定根用于可持续提取植物化学物质的情况。在本文中,我们努力回顾该领域的最新进展,了解不定根的诱导机制、其培养方法、影响生长和代谢产物产生的可能因素,并评估实现工业规模生产以满足对天然草药不断增长需求的可能性。